Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing mortality in sepsis: new directions.

Jean-Louis Vincent1, Edward Abraham, Djillali Annane

  • 1Department of Intensive Care, Erasme Hospital (Free University of Brussels), Brussels, Belgium. jlvincen@ulb.ac.be

Critical Care (London, England)
|May 2, 2003
PubMed
Summary

Implementing evidence-based interventions like low tidal volume ventilation and early goal-directed therapy can significantly reduce sepsis mortality. This guidance helps clinicians integrate these life-saving strategies into intensive care units.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency (HORNbILL): study protocol for a multicentre randomised placebo-controlled trial.

BMJ open·2026
Same author

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Critical care medicine·2026
Same author

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Rethinking fairness in unsupervised healthcare AI: A methodological scoping review.

Journal of biomedical informatics·2026
Same author

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.

Journal of neuromuscular diseases·2026
Same author

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Journal of thrombosis and haemostasis : JTH·2026

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Endocrinology

Background:

  • Sepsis remains a leading cause of mortality, necessitating improved clinical practices.
  • Translating research findings on sepsis interventions into routine clinical care presents challenges.

Purpose of the Study:

  • To provide expert guidance on integrating evidence-based sepsis interventions into intensive care unit (ICU) practice.
  • To facilitate the adoption of strategies shown to reduce sepsis-related mortality.

Main Methods:

  • A roundtable discussion with principal investigators of key sepsis mortality-reducing studies.
  • Consensus development on optimal patient selection and timing for interventions.

Main Results:

Related Experiment Videos

  • Five key interventions proven to reduce sepsis mortality were discussed: low tidal volume ventilation for acute lung injury/acute respiratory distress syndrome, early goal-directed therapy, drotrecogin alfa (activated), moderate-dose steroids, and tight glycemic control.
  • Recommendations were derived for the appropriate use of each intervention.
  • The synergistic effect of combining multiple interventions (an "ICU package") was emphasized.

    • Conclusions:

    • Individual interventions have a defined role in sepsis management.
    • A combination of therapies is often required for optimal sepsis care.
    • Guidelines are provided for integrating these interventions into ICU protocols to decrease mortality.